CSIMarket
 

Healthcare Sector

Biotechnology & Drugs Industry Profitability  


Profitability by Company within Biotechnology & Drugs Industry


Company Quarter Gross Margin Net Margin Cash flow Margin ROE
Abbvie Inc 3 Q 60.86 % 17.93 % 14.52 % 180.74 %
Arca Biopharma Inc 3 Q - - - -
American Bio Medica Corp 3 Q 26.61 % - - -
Acorda Therapeutics inc 3 Q 77.08 % 13.84 % 33 % 16.08 %
Aclaris Therapeutics Inc 3 Q 17.94 % - - -
Acasti Pharma Inc 2 Q - - - -
Actavis Plc 4 Q 27.97 % - - -
Ocata Therapeutics, Inc. 0 Q - - - -
Adaptimmune Therapeutics Plc 3 Q - - - -
Fennec Pharmaceuticals Inc. 0 Q - - - -
Adma Biologics Inc 3 Q - - - -
Adverum Biotechnologies Inc 3 Q - - - -
Aerie Pharmaceuticals Inc 3 Q 73.2 % - - -
Agenus Inc 3 Q 93.86 % - - -
Allergan plc 1 Q 82.71 % 10.51 % - -
Applied Genetic Technologies Corp 3 Q - - - -
Akers Biosciences Inc 3 Q - - - -
Alder Biopharmaceuticals Inc 2 Q - - - -
Alliance Bioenergy Plus, Inc. 1 Q - - - -
Allena Pharmaceuticals Inc 3 Q - - - -
Amarillo Biosciences Inc 3 Q 35.94 % - - -
Amarantus Bioscience Holdings, Inc. 0 Q - - - -
Amarantus Bioscience Holdings, Inc. 0 Q - - - -
Amgen Inc 3 Q - - - 72.12 %
Albany Molecular Research Inc 2 Q 23.83 % - 4.07 % -
Amyris Inc 3 Q 24.62 % - - -
Alpha Network Alliance Ventures Inc. 2 Q 33.16 % - 4.26 % -
Aeolus Pharmaceuticals, Inc. 4 Q - - - -
Apollo Endosurgery inc 3 Q 54.47 % - - -
Armata Pharmaceuticals Inc 3 Q - - - -
Cellect Biotechnology Ltd 4 Q - - - 113.28 %
Aptose Biosciences Inc 3 Q - - - -
Aptevo Therapeutics Inc 3 Q - - - -
Ariad Pharmaceuticals Inc 0 Q - - - -
Armo Biosciences, Inc. 1 Q - - - -
Arno Therapeutics, Inc 0 Q - - - -
Aerpio Pharmaceuticals Inc 3 Q - - - -
Aslan Pharmaceuticals Ltd 4 Q 86.42 % - - -
Assembly Biosciences inc 3 Q - - - -
Asterias Biotherapeutics, Inc. 1 Q 86.82 % - - -
Atara Biotherapeutics Inc 3 Q - - - -
Kubota Pharmaceutical Holdings Co Ltd 0 Q - - - -
Avantor Inc 2 Q 33.18 % 4.07 % 4.67 % 4.38 %
Anavex Life Sciences Corp 2 Q - - - -
Axim Biotechnologies Inc 2 Q - - - -
Axcella Health Inc 3 Q - - - -
Ayala Pharmaceuticals Inc 2 Q - - - -
Aytu Bioscience Inc 3 Q 71.75 % - - -
Azurrx Biopharma Inc 3 Q - - - -
Brickell Biotech Inc 3 Q - - - -
Brainstorm Cell Therapeutics inc 3 Q - - - -
Biocryst Pharmaceuticals Inc 3 Q 75.14 % - - -
Black Diamond Therapeutics Inc 3 Q - - - -
Beam Therapeutics Inc 2 Q - - - 1.68 %
Beesfree, Inc. 0 Q - - - -
Biofrontera Ag 4 Q 78.91 % - - -
Bg Medicine, Inc. 0 Q - - - -
U.s. Stem Cell, Inc. 3 Q 12.28 % - - -
Premier Biomedical Inc 4 Q - - - -
Biogen Inc 3 Q 86.7 % 20.85 % - 42.94 %
Bionovate Technologies Corp 3 Q - - - -
Berkeley Lights Inc 2 Q 65.87 % - - -
Immucor Inc 0 Q - - - -
Bluebird Bio Inc 3 Q 93.16 % - - -
Mj Biotech, Inc. 4 Q - - - -
Bionano Genomics Inc 3 Q 33.52 % - 5.33 % -
Bionovo Inc 0 Q - - - -
Audentes Therapeutics Inc 2 Q - - - -
Bohai Pharmaceuticals Group, Inc. 4 Q 76.61 % 15.54 % - 19.11 %
Organicell Regenerative Medicine Inc 4 Q 74.19 % - - -
Biorestorative Therapies, Inc. 3 Q - - - -
Boston Therapeutics Inc 4 Q - - - -
Biondvax Pharmaceuticals Ltd 4 Q - - - -
Burzynski Research Institute Inc 3 Q - - - -
Cabaletta Bio Inc 3 Q - - - -
Cadence Pharmaceuticals Inc 4 Q 67.3 % - - -
Cannis Inc 2 Q - - - -
Cannapowder Inc 4 Q - - - -
Capricor Therapeutics Inc 3 Q - - - -
Capstone Therapeutics Corp. 2 Q - - - -
Casi Pharmaceuticals Inc 3 Q 56.91 % - - -
Catalyst Biosciences Inc 3 Q - - - -
Cellular Biomedicine Group Inc 3 Q 76.41 % - - -
China Botanic Pharmaceutical 0 Q - - - -
China Biologic Products Holdings Inc 4 Q - 32.44 % - 9.21 %
Cellcyte Genetics Corp. 0 Q - - - -
Cidara Therapeutics Inc 3 Q - - - -
Chromadex Corporation 3 Q 59.62 % - - -
Cardax Inc 3 Q 58.62 % - - -
Creative Medical Technology Holdings Inc 3 Q 77.14 % - 2.19 % -
Cen Biotech Inc 3 Q - - - -
Cerecor Inc 3 Q 93.1 % - - -
Compugen Ltd 4 Q - - - -
Coherus Biosciences inc 3 Q - 24.6 % 59.75 % 88.44 %
Chelsea Therapeutics International, Ltd. 0 Q - - - -
China Kangtai Cactus Bio-tech, Inc. 0 Q - - - -
Celldex Therapeutics Inc 3 Q - - - -
Cellectis S a 4 Q 25 % - - -
Checkmate Pharmaceuticals Inc 2 Q - - - -
Clementia Pharmaceuticals Inc. 1 Q - - - -
Cell Medx Corp 3 Q 74.85 % - - -
United Cannabis Corp 3 Q - - - -
Cannabics Pharmaceuticals Inc 3 Q - - - -
Compass Biotechnologies Inc. 0 Q - - - -
Cohbar Inc 3 Q - - - -
Cocrystal Pharma Inc 3 Q - - - -
Core Lithium Corp. 3 Q - - - -
Cannapharmarx Inc 3 Q - - - -
Cardiff Oncology inc 3 Q - - - -
Curis Inc 3 Q - - - -
Crispr Therapeutics Ag 3 Q - - - -
American Cryostem Corp 2 Q 96.75 % - 12.54 % -
Champions Oncology Inc 2 Q 44.11 % 0.79 % - -
Cyclo Therapeutics Inc 3 Q - - - -
Cytomx Therapeutics Inc 3 Q - - - -
Citius Pharmaceuticals Inc 2 Q - - - -
Cue Biopharma Inc 3 Q - - - -
Cel sci Corporation 2 Q - - - -
Cv Sciences Inc 3 Q 44.18 % - - -
Cv Sciences, Inc. 1 Q 68.91 % 7.67 % - -
Cyanotech Corp 3 Q 38.51 % 1.81 % 10.83 % 3.67 %
Cytodyn Inc 3 Q - - - -
Cytrx Corp 3 Q - - - -
Dbv Technologies S a 4 Q - - - -
Enochian Biosciences Inc 3 Q - - - -
Diadexus, Inc. 0 Q - - - -
Diffusion Pharmaceuticals Inc 3 Q - - - -
Dimension Therapeutics, Inc. 3 Q - - - -
Dna Testing Centers Corp 4 Q - - - -
Dendreon Corp 0 Q - - - -
Denali Therapeutics Inc 3 Q - - - 6.7 %
Noho, Inc. 0 Q - - - -
Ds Healthcare Group, Inc. 2 Q 58.96 % - - -
Dyadic International Inc 3 Q 35.89 % - - -
Emergent Biosolutions Inc 3 Q 61.32 % 10.25 % 37.95 % 14.44 %
Pds Biotechnology Corp 3 Q - - - -
Eidos Therapeutics Inc 3 Q - - - -
Eiger Biopharmaceuticals Inc 3 Q - - - -
Eloxx Pharmaceuticals Inc 2 Q - - - -
Empowered Products, Inc. 0 Q - - - -
Endonovo Therapeutics Inc 3 Q 98.1 % - - -
Entremed Inc 0 Q - - - -
Entest Group Inc 4 Q - - - -
Enumeral Biomedical Holdings, Inc. 3 Q - - - -
Enzon Pharmaceuticals Inc 3 Q - - - -
Enzymotec Ltd. 0 Q - - - -
Entia Biosciences, Inc. 4 Q 77.99 % - - -
Erytech Pharma S a 4 Q - - - -
Establishment Labs Holdings Inc 2 Q 69.07 % - - -
Eastgate Biotech Corp 2 Q 50.28 % - 34.44 % -
89bio Inc 3 Q - - - 16.04 %
Evelo Biosciences Inc 3 Q - - - -
Eyenovia Inc 3 Q - - - -
Fate Therapeutics inc 3 Q - - - -
Fennec Pharmaceuticals Inc 3 Q - - - -
Homology Medicines Inc 2 Q - - - -
Fulgent Genetics Inc 3 Q 74.18 % 45.85 % 49.75 % 43.55 %
Forma Therapeutics Holdings Inc 2 Q - - - -
Foamix Pharmaceuticals Ltd 4 Q - - - 181.74 %
Frequency Therapeutics Inc 3 Q - - - -
Global Future City Holding Inc. 1 Q 64.93 % - - -
Fusion Pharmaceuticals Inc 2 Q - - - -
Genetic Technologies Ltd 2 Q - - - -
Gentium S.p.a. 0 Q - - - -
Synageva Biopharma Corp 0 Q - - - -
Gilead Sciences Inc 3 Q 82.65 % 5.37 % 93.36 % 6.14 %
Glucose Health, Inc. 3 Q 96.68 % 78.92 % - -
Genocea Biosciences Inc 3 Q - - - -
Aevi Genomic Medicine, Inc. 3 Q - - - -
Gossamer Bio Inc 3 Q - - - -
Green Planet Bio Engineering Co Ltd 3 Q - - - -
Optec International, Inc. 1 Q - - - -
Gritstone Oncology Inc 3 Q - - - -
Galera Therapeutics Inc 3 Q - - - -
Guided Therapeutics Inc 3 Q 84.42 % - - -
Genethera Inc 3 Q - - - -
G1 Therapeutics Inc 3 Q - - 15.32 % -
Gtx Corp 3 Q 48.84 % 0.86 % - -
Halozyme Therapeutics Inc 2 Q 89.61 % 46.75 % 52.13 % -
Hubei Minkang Pharmaceutical Ltd. 0 Q - - - -
Health Discovery Corp 3 Q - - - -
Aim Immunotech Inc 3 Q - - - -
Inhibitor Therapeutics Inc 3 Q - - - -
Hyperion Therapeutics Inc 0 Q - - - -
Heska Corp 1 Q 43.87 % - - -
Hst Global Inc 3 Q - - - -
Idera Pharmaceuticals Inc 3 Q - - - -
Igm Biosciences Inc 3 Q - - - -
Intelgenx Technologies Corp 3 Q - - 27.06 % -
Intellect Neurosciences, Inc. 4 Q - - - -
Immuron Ltd 2 Q 72.65 % - - -
Conversion Labs Inc 3 Q 75.15 % - 5.27 % -
Epicure Charcoal, Inc. 4 Q - - - -
Immunomedics Inc 2 Q 91.69 % - - -
Immune Therapeutics Inc 3 Q - - - -
Immunovant Inc 3 Q - - - -
Integrated Biopharma Inc 3 Q 15.64 % 6.86 % - 94.28 %
Infinity Pharmaceuticals Inc 3 Q - - - -
Artemis Therapeutics Inc 3 Q - - - -
Innovus Pharmaceuticals, Inc. 3 Q 61.51 % - - -
Iovance Biotherapeutics inc 2 Q - - - -
Iteos Therapeutics Inc 2 Q - - - -
Iterum Therapeutics Plc 3 Q - - - -
Renovacare Inc 3 Q - - - -
Jounce Therapeutics Inc 1 Q - - - 74.73 %
Juno Therapeutics, Inc. 4 Q - - - -
Cadus Corp 1 Q - - - -
Kite Pharma, Inc. 2 Q - - - -
Krystal Biotech Inc 3 Q - - - -
Kitov Pharma Ltd 4 Q - - - 54.27 %
Kazia Therapeutics Ltd 2 Q - - - -
Lescarden Inc 0 Q - - - -
Lineage Cell Therapeutics Inc 3 Q 82.14 % - - -
Atyr Pharma Inc 3 Q - - - -
Lixte Biotechnology Holdings Inc 3 Q - - - -
La Jolla Pharmaceutical Company 3 Q 72.56 % - - -
Lazuriton Nano Biotechnology u s a Inc 3 Q - - - -
Apollo Endosurgery, Inc. 1 Q 58.38 % - - -
Livongo Health Inc 2 Q 76.65 % - - 1.36 %
Luckwel Pharmaceuticals Inc. 2 Q - - - -
Mateon Therapeutics Inc 1 Q - - - -
Mabvax Therapeutics Holdings, Inc. 3 Q 80.38 % 8.52 % 5.63 % -
Multicell Technologies, Inc. 4 Q - - - -
Cannabis Global Inc 3 Q - - - -
Madrigal Pharmaceuticals Inc 3 Q - - - -
Manhattan Pharmaceuticals Inc 0 Q - - - -
Micromet, Inc. 0 Q - - - -
Mj Pharmaceuticals Inc. 0 Q - - - -
Cure Pharmaceutical Holding Corp 3 Q 24.48 % - - 31.23 %
Momenta Pharmaceuticals inc 2 Q - - - -
Banner Energy Services Corp 2 Q - - - -
Medicure Inc 4 Q 63.95 % - - -
Merus N v 3 Q - - - -
Midatech Pharma Plc 4 Q - - - -
Myriad Genetics Inc 3 Q 72.52 % - - -
Mymetics Corp 3 Q - - - -
Myokardia Inc 3 Q - - - -
Myrexis, Inc. 0 Q - - - -
Navidea Biopharmaceuticals Inc 3 Q 99.97 % - - -
Nascent Biotech Inc 3 Q - - - -
Neurocrine Biosciences Inc 3 Q 98.96 % - 3.95 % 12.57 %
Northsight Capital, Inc. 2 Q - - 12.19 % -
Neogen Corp 3 Q 46.01 % 14.51 % - 8.43 %
Nexus Biopharma Inc 0 Q - - - -
Nightstar Therapeutics Plc 1 Q - - - -
Nantkwest Inc 3 Q - - - -
Neoleukin Therapeutics Inc 3 Q - - - -
Biovie Inc 3 Q - - - -
Nutra Pharma Corp. 1 Q 81.96 % - 5.96 % -
Nanostring Technologies Inc 3 Q 56.16 % - 9.14 % -
Intellia Therapeutics Inc 3 Q - - - -
Nbty Inc 4 Q 46.59 % 6.51 % - -
Nugene International, Inc. 0 Q - - - -
Nutrastar International Inc. 0 Q - - - -
Novavax Inc 3 Q - - - -
N-viro International Corporation 0 Q - - - -
Nexien Biopharma Inc 3 Q - - - -
Nymox Pharmaceutical Corporation 4 Q 50 % - - -
Obalon Therapeutics Inc 3 Q 6.82 % - - -
Oncbiomune Pharmaceuticals Inc 1 Q - - - -
Ocugen Inc 3 Q - - - -
Oncocyte Corp 3 Q - - - -
Spark Therapeutics Inc 2 Q 90.39 % - - -
Oncternal Therapeutics Inc 3 Q - - - -
Outlook Therapeutics Inc 2 Q - - - -
Organovo Holdings Inc 3 Q - - - -
Orgenesis Inc 3 Q - - - -
Osiris Therapeutics, Inc. 1 Q 72.01 % - - 8.17 %
Oncovista Innovative Therapies, Inc 0 Q - - - -
Oxford Immunotec Global Plc 3 Q 76.45 % - - -
Mateon Therapeutics Inc 3 Q - - - -
Gt Biopharma Inc 3 Q - - - -
Oyster Point Pharma Inc 3 Q - - - -
Prolor Biotech, Inc. 0 Q - - - -
Vaxcyte Inc 2 Q - - - -
Procyon Corp 3 Q 73.17 % 17.58 % 0.63 % 11.13 %
Pdl Biopharma Inc 3 Q 40.67 % - - -
Quint Media Inc. 0 Q - - - -
Petvivo Holdings Inc 2 Q - - - -
Phathom Pharmaceuticals Inc 3 Q - - - -
Protokinetix Inc 3 Q - - - -
Pulse biosciences inc 3 Q - - - -
Protalix Biotherapeutics inc 3 Q 73.42 % - 80.54 % -
Pharmacyte Biotech Inc 2 Q - - - -
Predictive Oncology Inc 3 Q 63.56 % - - -
Prana Biotechnology Ltd 2 Q - - - -
Precipio Inc 3 Q 23.17 % - - -
Pluristem Therapeutics Inc 3 Q - - - -
Poseida Therapeutics Inc 2 Q - - - -
Proteo Inc 1 Q - - - -
Portage Biotech Inc 1 Q - - - -
Protagonist Therapeutics inc 3 Q - - - -
Proteostasis Therapeutics Inc 3 Q - - - -
Pulmatrix Inc 3 Q - - - -
Pivot Pharmaceuticals Inc. 1 Q - - - -
Q Biomed Inc 3 Q - - - -
Quidel Corporation 3 Q 80.58 % 48.79 % 1.04 % 56.48 %
Qiagen N v 4 Q 65.86 % - - -
Quest Patent Research Corp 3 Q - 1.46 % - -
Qrons Inc 3 Q - - - -
Quotient Limited 2 Q 39.33 % - 38.17 % -
Quanterix Corp 2 Q 39.7 % - - -
Quint Media Inc. 0 Q - - - -
Rapt Therapeutics Inc 3 Q - - - -
Rich Pharmaceuticals, Inc. 4 Q - - - -
Regenocell Therapeutics, Inc. 0 Q - - - -
Receptos, Inc. 0 Q - - - -
Arcus Biosciences Inc 3 Q - 2.82 % - -
Ridgefield Acquisition Corp 3 Q - - - -
Replicel Life Sciences Inc. 4 Q - - - -
Restorgenex Corp 0 Q - - - -
Reynolds Consumer Products Inc 2 Q 30.66 % 13.63 % 23.36 % -
Regen Biopharma Inc 2 Q - - - -
Regado Biosciences Inc 0 Q - - - -
Repligen Corp 3 Q 57.87 % 15.47 % - 4.03 %
Regenxbio Inc 3 Q 82.45 % 8.89 % - -
Regenerx Biopharmaceuticals Inc 3 Q - - - -
Riot Blockchain Inc 3 Q 47.12 % - - -
Relay Therapeutics Inc 2 Q - - - -
Relmada Therapeutics Inc 3 Q - - - -
Royalty Pharma Plc 2 Q 90.75 % - - 25.22 %
Respirerx Pharmaceuticals Inc 3 Q - - - -
Aytu Bioscience, Inc. 0 Q - - - -
Ruthigen, Inc. 0 Q - - - -
Rubius Therapeutics inc 2 Q - - - -
Revolution Medicines Inc 2 Q - - - -
Radient Pharmaceuticals Corp 0 Q - - - -
Strongbridge Biopharma plc 3 Q 94.94 % - - -
Scpharmaceuticals Inc 3 Q - - - -
Sangui Biotech International Inc 3 Q - - 29.39 % -
Seagen Inc 3 Q 92.63 % 59.92 % 75.55 % 24.5 %
Sangamo Therapeutics Inc 3 Q - - - -
Shengtai Pharmaceutical, Inc. 0 Q - - - -
Skinovation Pharmaceutical Inc 3 Q - - - -
Skinvisible Inc 3 Q - - - -
Solid Biosciences Inc 3 Q - - - -
Salarius Pharmaceuticals inc 3 Q - - - -
Sun Biopharma Inc 3 Q - - - -
Seneca Biopharma Inc 3 Q - - - -
Syndax Pharmaceuticals Inc 3 Q - - - -
Soligenix Inc 3 Q 36.49 % - 28.66 % -
Sienna Biopharmaceuticals, Inc. 3 Q - - - -
Senesco Technologies Inc 0 Q - - - -
Senesco Technologies Inc 4 Q - - - -
Spero Therapeutics Inc 3 Q - - - -
Surgalign Holdings Inc 3 Q 57.42 % - - -
Scholar Rock Holding Corp 2 Q - - - -
Neuronetics Inc 3 Q 78.66 % - - -
Spotlight Innovation Inc. 1 Q 80.25 % - - -
Satsuma Pharmaceuticals Inc 3 Q - - - -
Surface Oncology Inc 3 Q - - - -
Sunwin Stevia International Inc 2 Q 2.37 % - - -
Intellicell Biosciences, Inc. 0 Q - - - -
Savient Pharmaceuticals Inc 0 Q - - - -
Springworks Therapeutics Inc 3 Q - - - -
Protara Therapeutics Inc 3 Q - - - -
Tobira Therapeutics, Inc. 0 Q - - - -
Tracon Pharmaceuticals Inc 3 Q - - - -
Bio techne Corp 3 Q 67.45 % 16.35 % 11.16 % 18.27 %
Telik Inc 0 Q - - - -
Mabvax Therapeutics Holdings, Inc. 0 Q - - - -
Tongli Pharmaceuticals (usa), Inc. 4 Q - - - -
Tg Therapeutics inc 3 Q - - - -
Tg Therapeutics, Inc. 0 Q - - - -
Twinlab Consolidated Holdings Inc 3 Q 20.15 % - 2.28 % -
Mitesco Inc 3 Q - - - -
Targeted Medical Pharma, Inc. 0 Q - - - -
Targacept Inc 0 Q - - - -
Therapix Biosciences Ltd. 2 Q - - - -
Therapeutic Solutions International Inc 3 Q 76 % - - -
Trius Therapeutics Inc 0 Q - - - -
Taxus Pharmaceuticals Holdings, Inc. 1 Q - - - -
Unity Biotechnology Inc 3 Q - - - -
Uluru Inc. 1 Q 68.55 % - - -
United Bancshares Inc 0 Q - - - -
Urogen Pharma Ltd 3 Q 91.07 % - - -
Urovant Sciences Ltd 3 Q - - - -
Avricore Health Inc. 4 Q - - - -
Vitality Biopharma Inc 3 Q - - - -
Vericel Corporation 3 Q 69.66 % 11.22 % - 0.13 %
Vir Biotechnology Inc 3 Q - - - -
Meridian Bioscience Inc 3 Q 60.02 % 10.12 % - 20.93 %
Volitionrx Ltd 3 Q - - - -
Viropharma Inc 0 Q - - - -
Vistagen Therapeutics Inc 3 Q - - - -
Ventrus Biosciences Inc 0 Q - - - -
Vaxart Inc 3 Q - - - -
Voyager Therapeutics Inc 3 Q - 72.65 % 2.65 % 37.97 %
Warner Chilcott Plc 0 Q - - - -
Windtree Therapeutics Inc 3 Q - - - -
Weikang Bio-technology Group Co., Inc. 0 Q - - - -
Wave Life Sciences Ltd 3 Q - - - -
Xenetic Biosciences Inc 3 Q - - - -
Acceleron Pharma inc 3 Q - - - -
Xstelos Holdings, Inc. 0 Q - - - -
Vilacto Bio Inc. 2 Q 18 % - - -
Zai Lab Limited 4 Q 71.13 % - - -
Zymeworks Inc 3 Q - - - -
Profitability
Biotechnology & Drugs Industry
Gross margin contracted to 65.74 % in the 3. Quarter 2020 from 69.75 % in previous quarter, now Ranking #19 and ranking within sector #1.
Net margin for Biotechnology & Drugs Industry is 8.27 % above industry average.

More on Biotechnology & Drugs Industry Profitability

Biotechnology & Drugs Industry achieved cash flow margin of 25.77 % and above average return on equity of 4.13 %

More on Biotechnology & Drugs Industry Cash flow
More on Biotechnology & Drugs Industry ROE







Cardiovascular Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q




       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GTXO's Profile

Stock Price

GTXO's Financials

Business Description

Fundamentals

Charts & Quotes

GTXO's News

Suppliers

GTXO's Competitors

Customers & Markets

Economic Indicators

GTXO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071